Carregant...

Methodological Issues in Negative Symptom Trials

Individuals from academia, the pharmaceutical industry, and the US Food and Drug Administration used a workshop format to discuss important methodological issues in the design of trials of pharmacological agents for improving negative symptoms in schizophrenia. The issues addressed included the need...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Marder, Stephen R., Daniel, David G., Alphs, Larry, Awad, A. George, Keefe, Richard S. E.
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2011
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3044631/
https://ncbi.nlm.nih.gov/pubmed/21270473
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbq161
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!